Source: Spinler SA, De Denus
S. Acute Coronary Syndromes. In: DiPiro JT, Talbert RL, Yee GC,
Matzke GR, Wells BG, Posey LM, eds. Pharmacotherapy:
A Pathophysiologic Approach. 8th ed. http://accesspharmacy.com/content.aspx?aid=7972196.
Accessed June 30, 2012.
- Acute coronary syndromes (ACS) includes all clinical syndromes
of acute myocardial ischemia resulting from an imbalance between
myocardial oxygen demand and supply.
- Diminished myocardial blood flow secondary to occlusive
or partially occlusive coronary artery thrombus
- Partially or completely occlusive clot forms on top of
ruptured atherosclerotic plaque within coronary artery.
- Release of adenosine diphosphate and thromboxane A2 from
platelets produces vasoconstriction and platelet activation.
- Activation of extrinsic coagulation cascade leads to formation
of fibrin clot.
- Ventricular remodeling after myocardial infarction (MI) may
lead to heart failure (HF).
- >1.2 million Americans experience ACS each year; 220,000
die of MI.
- Up to 6.3 million emergency department visits each year are
linked to possible ACS.
- >17.6 million in U.S. have coronary heart disease (CHD).
- Risk factor modification (smoking cessation; control of
blood pressure, diabetes, dyslipidemia)
- Symptoms: Chest discomfort (usually at rest), severe new-onset
or increasing angina. Discomfort may radiate to shoulder, down left
arm, or to back or jaw. Nausea, vomiting, diaphoresis, and shortness
of breath may also occur.
- Signs: Patients with ACS may present with signs of acute HF
Means of Confirmation
- Use patient symptoms, past medical history, ECG, and troponin
or CK-MB to stratify patients into low, medium, or high risk.
- Increased troponin I or T with a typical rise and fall
- Increased CK-MB may be used if troponin test is not available.
- Serum potassium and magnesium, glucose, serum creatinine,
complete blood cell count (CBC), coagulation tests, and fasting
- 12-lead ECG findings indicating myocardial ischemia or
MI include ST-segment elevation, ST-segment depression, and T-wave
- Classification of ACS
- ST-segment elevation
(STE) ACS or STE MI
- Non–ST-segment elevation (NSTE) ACS, which includes
non–ST-segment elevation myocardial infarction (NSTE MI)
and unstable angina (UA)
- Early restoration of blood flow to the infarct-related
- Prevention of complications and death
- Prevention of coronary artery reocclusion
- Relief of ischemic chest discomfort
- Resolution of ST-segment and T-wave changes on ECG
- Hospital admission, oxygen if saturation <90%,
continuous ST-segment monitoring, glycemic control, frequent vital
sign measurement, bedrest, stool softeners, and pain relief
- For patients with STE MI, attempt to reestablish coronary
perfusion immediately (without evaluation of biochemical markers).
- Obtain serial biochemical markers in patients with NSTE ACS
who are low risk.
- High-risk NSTE ACS patients should undergo early coronary
angiography (within 12–24 hours) and revascularization
if significant stenosis is ...
Log In to View More
If you don't have a subscription, please view our individual subscription options below to find out how you can gain access to this content.
Want remote access to your institution's subscription?
Sign in to your MyAccess profile while you are actively authenticated on this site via your institution (you will be able to verify this by looking at the top right corner of the screen - if you see your institution's name, you are authenticated). Once logged in to your MyAccess profile, you will be able to access your institution's subscription for 90 days from any location. You must be logged in while authenticated at least once every 90 days to maintain this remote access.
If your institution subscribes to this resource, and you don't have a MyAccess profile, please contact your library's reference desk for information on how to gain access to this resource from off-campus.
AccessPharmacy Full Site: One-Year Subscription
Connect to the full suite of AccessPharmacy content and resources including 30+ textbooks such as Pharmacotherapy: A Pathophysiologic Approach and Goodman & Gilman's The Pharmacological Basis of Therapeutics, high-quality videos, images, and animations, interactive board review, drug and herb/supplements databases, and more.
Pay Per View: Timed Access to all of AccessPharmacy
24 Hour Subscription $34.95
48 Hour Subscription $54.95
Pop-up div Successfully Displayed
This div only appears when the trigger link is hovered over.
Otherwise it is hidden from view.